BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 24115036)

  • 1. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
    Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner.
    Wezel A; van der Velden D; Maassen JM; Lagraauw HM; de Vries MR; Karper JC; Kuiper J; Bot I; Quax PH
    Atherosclerosis; 2015 Jan; 238(1):132-9. PubMed ID: 25484103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
    Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population.
    Grimm M; Tischner D; Troidl K; Albarrán Juárez J; Sivaraj KK; Ferreirós Bouzas N; Geisslinger G; Binder CJ; Wettschureck N
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):37-48. PubMed ID: 26603156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia-associated alterations in B cell subpopulation frequency and phenotype during experimental atherosclerosis.
    Rincón-Arévalo H; Castaño D; Villa-Pulgarín J; Rojas M; Vásquez G; Correa LA; Ramírez-Pineda JR; Yassin LM
    Atherosclerosis; 2016 Apr; 247():118-26. PubMed ID: 26897258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
    Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
    Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
    Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.
    Herías V; Biessen EA; Beckers C; Delsing D; Liao M; Daemen MJ; Pham CC; Heeneman S
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):79-86. PubMed ID: 25395616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
    Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titration of the gap junction protein Connexin43 reduces atherogenesis.
    Morel S; Chanson M; Nguyen TD; Glass AM; Richani Sarieddine MZ; Meens MJ; Burnier L; Kwak BR; Taffet SM
    Thromb Haemost; 2014 Aug; 112(2):390-401. PubMed ID: 24828015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cluster of differentiation 43 deficiency in leukocytes leads to reduced atherosclerosis--brief report.
    Meiler S; Baumer Y; McCurdy S; Lee BH; Kitamoto S; Boisvert WA
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):309-11. PubMed ID: 25524774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.